Early detection of the self-limiting or chronic tendency towards disease at the beginning of the hepatitis process is a canonical element of the analysis and synthesis to formulate the diagnosis and to decide the most useful and economic therapeutic strategy. Early treatment with antiviral drugs before liver functions undergo deterioration may reduce death and disability especially in young patients.
INTRODUCTION
This study is based on the observation that the morphology of the alanine-aminotransferase (ALT) enzyme curves of a first episode of liver viral cytolysis resemble the Max Planck curves describing the relationship between the emission of electromagnetic radiation per unit surface area of a blackbody versus time and wavelength (Herzberg et al, 1945 , Planck, 1956 , Leconte et al, 1958 , Eisberg et a1 1974 , Tipler, 1977 . The Planckian formula suggested a new equation that allows the inclusion of just a few initial *Corresponding Author: Tel: +39-02-82244501; Fax: +39-02-82244590 **Supported by a grant from Gilette S.p.A., Italy serum ALT measurements to produce mathematical curves that closely resemble the natural behaviour of the hepatitis process.
The aim of the study was to investigate whether these curves provide an early prediction of the duration of the first episode of liver viral cytolysis in relation to the temporal threshold of 180 days that defines the chronic evolution of the disease. Such a prediction is useful above all in the case of C virus related hepatitis which easily evolves towards chronicity. In this case the patients with self-limiting disease would be excluded from therapeutic regimens involving antiviral drugs, whereas those who have a potentially chronic form of the disease need to undergo therapy as early as possible during the initial phase of the process in order to prevent chronic evolution. Since the later treatments are applied the less active they prove to be, information that can put in evidence sufficiently early the needs of the patients and may also achieve a more favourable cost-effectiveness ratio of the antiviral treatment could prove to be very interesting.
PATIENTS AND METHODS

Human Subjects
This study was conducted according to the guidelines of the Ethics Committees of the hospitals treating the patients, despite the fact that it could not cause any distress or risk; all of the patients (who were aged 18-58 years) were fully informed.
To avoid exceeding the economic limits imposed by the Diagnosis Related Groups system, and to give a small contribution to private medicine (which is heavily penalised by the inequality of the economic and scientific provisions of the Italian Health Authorities), the serum ALT recordings were strictly limited to those judged to be clinically opportune by the attending physicians without any predetermined times of detection.
The 59 enrolled patients included eight with HAV-correlated hepatitis, 17 with HBV-correlated hepatitis, 28 with HCV-correlated hepatitis (three of whom were being treated with interferon), four with Epstein-Barr virus-correlated hepatitis, one with both HAV and Epstein-Ban virus-correlated hepatitis, and one with cytomegalovirus (CMV)-correlated hepatitis. The cases were provided by San Paolo Hospital of Milan (M. Podda), Milan University's Infectious Diseases Clinic (M. Moroni), and the Internal Medicine Department of Melegnano Hospital (G. Benetti).
The study started in February 1993 and ended in February 1998.
Enzyme Assay
ALT values were measured under normal conditions using a standard method whose normal serum values are less than 40 IU/ml.
Mathematical Method
The mathematical relationship is expressed by the equation, where e is the Eulers number and k a generic constant.
The mathematical curves that can be obtained using this equation are characterized by the following three parameters:
-parameter a, which is proportional to the maximum height of the curve; -parameter b, which is proportional to the position of the apex of the curve on the x axis; -parameter c, which is proportional to the width of the curve (Figure 1 ). When x is replaced by time ( t ) expressed in days, y by the value of ALT expressed in IU/ml of serum, and k by the mean normal serum ALT value of t40 I U / d (arbitrarily defined as 30 IUlml of serum), equation (2) In this equation, the three parameters a, b, and c have a precise medical significance.
Parameter a is dependent on the highest ALT value (ALTM) and is considered to be the index of maximum intensity of the cytolytic process. The mathematical relationship linlung parameter a with ALTM is expressed by the equation,
where 21.2 is the gradient of the straight line (a, ALTM) graph obtained by numerical calculation, and 30 the arbitrarily defined mean normal serum ALT value of t 4 0 IU/ml. Parameter a is independent of parameters b and c.
Parameter b is dependent on parameter c and is a function of the position in time (days of observation) of the highest ALT value (XALTM).
The mathematical relationship of parameters b, c, and XALTM is expressed by the equation,
in which the coefficient of 115 has been obtained by numerical calculation and represents the gradient of the straight line (c, b) graph. Parameter c is the index of the temporal evolution of the simulated process and is dependent on the width of the mathematical curve simulating the process itself. Figure 2 shows that the greater the value of c, the wider the curve expressing the length of the episode in the patient under observation.
On the basis of just a few serum ALT measurements, the simulation software written by one of the authors of this paper (A.B.), calculates the parameters a , b, c, includes their values in equation (2), and provides the mathematical curve simulating the hepatitis process within a few seconds.
The ideal condition for constructing the mathematical simulations is when data is available from the phase of ascending ALT levels, and there is at least one data point belonging to the phase of descending levels (but better 2-4). In this case, the mathematical curve intersects the line corresponding to the maximum normal serum ALT value of 40 IUlml at two points (tl and t 2 ) , which respectively define the beginning and the end of the simulation process (Figure 3) . Point r2 has been called the G point and, when it lies beyond the conventional threshold of 180 days after the start of the simulation, provides a good prediction of the chronic evolution of the disease. Under these conditions, the curve provides a mathematical simulation of the entire process.
However, a curve can also be constructed using only 3-4 data points from the phase of descending FIGURE 2 width of the curve, thus simulating a greater duration of the phenomenon.
Graph of equation ( 2 ) showing the parameter c variable. It can be seen that an increase in c leads to an increase in the
The two intersections of the curve on the line indicating a serum ALT value of 40 units/ml are denoted ti and 12. They delimit the duration of the period of above-normal ALT values given by the mathematical simulation. The point tl indicates the theoretical start day of the process and point 12 its theoretical end day.
ALT levels. In this case, the mathematical curve hepatitis for whom 11 ALT measurements were simulates the evolution of the process only from available from the beginning to the end of the the first ALT datum and crosses the normal ALT disease (Table I) . The values of the three mathevalue line only at the G point. The threshold of matical parameters of the curve obtained by enter-180 days is calculated from the first day of clinical ing all of the ALT measurements in the simulation observation.
software were a = 72, b = 7.8 and c = 94. The following prototypical examples explain the When parameters a, b and c were calculated using use of the simulation in the two cases.
the four data points before the peak of the cytolytic a) When data before and after the apex of the process and only one datum after this event, their clinical ALT curve are available. The patient range of error was approximately 10-11%. The was a 60-year old woman with CMV-dependent same parameters calculated using an increasing number of data points until the last led to the error being reduced to nearly zero (Table 11 ). The use of these values in equation (2) 
RESULTS
The 59 patients were divided into two main groups on the basis of the phase of the disease at the time they were placed under medical care: the first group consisted of 40 patients (three of whom were being treated with interferon) who were observed throughout the course of the disease, and the second of 19 patients who were only seen during the decreasing phase of the cytolytic process. The results are presented in terms of the acute or chronic clinical evolution of the first disease episode on the basis of the incidence of G point values over the conventional 180-day threshold. Table IV summarizes the results obtained in the 37 patients for whom ALT data relating to both the ascending and the initial descending phases of the ALT curve were available. In 22 of these cases, the duration of clinically high ALT levels was less than 180days: the mean G point was 102.95 f 38.2 days (range: 34-177 days), and the mean time of prediction was 25.5 f 12.3 days (range: 7-60 days). In the remaining 15 patients, the duration of high ALT levels was more than 180 days, with a mean G point of 399.26 f 161.18 days (range: 229-747days), and a mean time of prediction of 49.3 f 19.9 days (range: 30-96 days). Table VI shows the baseline characteristics of the patients for whom data relating to the ascending and descending phases of the ALT curves were available, and Table VII the baseline characteristics of the patients for whom only ALT data of the descending phase were available. Table VIII shows the data relating to the three patients in whom the prediction failed because they were being treated with interferon therapy. 
DISCUSSION
The various types of viral hepatitis are considered endemic throughout the world and even hyperendemic in some areas. Cirrhosis, the chronic sequela of many forms of hepatitis, involves considerable social and financial costs, poses a number of ethical problems, leads to the loss of a large number of working hours and remains one of the most frequent causes of death. Given that the cost of treating both the acute and chronic phase of the unvaccinable forms of hepatitis is destined to rise, there is growing interest in the possibility of being able to distinguish as early as possible the patients with self-limiting hepatitis that do not need it. On the contrary in an attempt to stop the chronical evolution of the disease the patients affected by a potentially chronic form need to undergo antiviral treatments during the initial phases of the process without waiting 6-9 months, even if the liver functions are not decompensated or decreased. This is urgent especially in young patients because: a) they are more sensitive to the antiviral treatment; b) despite the natural history, the information about the long-term clinical and economical outcome of chronic hepatitis remains controversial, the suggestion that it is a life-shortening disease is an unquestionable fact; c) long-term interferon treatment, despite its high cost and failures in many patients, prolongs life expectancy intrinsically reduced by the course of the disease; d) the only exclusion criterion of the therapeutic intervention is very low grade of inflammation. The combination of these four conditions remains a very intriguing and disquieting problem not only for physicians but also for the most imperturbable economist (Buti, 1998; Koff, 1998; Messori, 1998) . In brief, the possibility of making such a dichotomy between treatable and untreated patients, considered not feasible up till today, could avoid the indiscriminate use of some treatments during the acute phase of the disease as well as the uneconomic wait until the passing of the threshold time indicating chronic disease.
However, despite our increasing understanding of the various types of viral and toxic hepatitis, there is still no method that is capable of providing circumstantial evidence concerning their acute or chronic destiny. The temporal determination of ALT levels alone is not predictive because the chronic evolution of these diseases can currently only be revealed a posteriori by detecting the nonnormalization of serum ALT levels 6-12 months after an acute episode or the non-clearance of hepatitis viruses due to their persistent replication up to one year after infection (both of which require expensive analytical methods), or by detecting hepatocyte necrosis, inflammation and fibrosis at liver biopsy.
This study started from the fact that the evolution of many natural phenomena (Fermi, 1966 , Weiss, 1994 , Jensen et al, 1995 , Sherman, 1995 , Wise er al, 1995 , including the behaviour of AL. T levels during hepatitis, recalls the morphology of Planckian curves. This observation led to the writing of a formula (derived from the Planck equation) that produces curves using just a few data points measured during the days after the highest ALT value is reached. The curves cross the line of normal ALT values at what is called the G point on the temporal axis, which seems to predict well in advance whether the initial phase of the disease will last longer than the 180 days considered to be the threshold of chronicity.
The prediction curves can be constructed using a minimum number of three data points measured at the beginning of the descending phase of the disease. The G point obtained from these simulations cannot predict the definitive acute conclusion of HCVdependent hepatitis when it indicates a simulated duration of less than 180 days because the disease may reemerge after a first short and only apparently conclusive episode; however, it does seem to predict chronic evolution if it indicates a duration of more than 180 days.
The G point provided a good prediction of the acute or chronic destiny of the first cytolytic episode in 56 of our 59 cases; the three wrong predictions all involved patients being treated with interferon. This paper cannot go beyond making a preliminary proposal that takes the parameters a and c provided by equation (2) as numerical markers predicting the behaviour of necrosis: parameter a provides an index of its maximal intensity and parameter c an index of its possible temporal evolution.
Mathematical representations of ALT behaviour during hepatitis can be obtained using other statistical functions, such as y -and log-normal distribution, but the fact that these functions only provide dependent parameters makes it more difficult to obtain indices that separately represent the severity and duration of the cytolytic event; furthermore, they assign meanings and virtues that are different from those provided by the formula proposed in this study.
The independence of parameters a, b and c that allows the empirical temporal ALT curve to be transformed into a semi-deterministic mathematical curve provides insights into the stochastic behaviour of hepatitis processes that go beyond the critical horizon offered by direct observation during the early disease phase. It can thus be hypothesised that a few early ALT measurements are capable of providing information concerning the initial conditions determining the evolution of the process, and that this information determines the predictive power of the formula to give an early indication as to whether the disease may evolve chronically. If this virtue is confirmed, it may become possible to propose its use for the study of other kinds of non-linear stochastic medical and non-medical phenomena that are characterized by behaviours whose trajectories are similar to the Planckian curve.
